Access NT-proBNP
Test, Natriuretic Peptide. 510(k) K232164, from Beckman Coulter, Inc. (Chaska, MN). Product code NBC, class 2.
As of Nov 19, 2026, K232164 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Apr 12, 2024 after 266 days, with no recalls tied to it in FDA's recall database.
- Review time: 266 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Access NT-proBNP assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of N-terminal pro B-type natriuretic peptide levels in human serum and plasma using the automated DxI Access Immunoassay Analyzers to aid in the following: 1. diagnosis of patients suspected of having acute heart failure in the Emergency Department 2.
- Elecsys Probnp Ii, Precicontrol Cardiac Ii, Probnp Ii CalsetK072437 · Roche Diagnostics · Feb 5, 2008
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK262597 · Beckman Coulter, Inc. · Oct 20, 2026
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity iK253539 · Axis-Shield Diagnostics, Ltd. · Feb 18, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK210546 · Roche Diagnostics · Mar 31, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 21, 2023
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files